Expert Opinion on Drug Metabolism & Toxicology, Volume 11, Issue 1 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 11, Issue 1 (2015)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Volume 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Human induced pluripotent stem cell-derived hepatocytes for toxicology testing
David A Mann (Product Manager) PhD
Pages: 1-5
Published online: 11 Nov 2014
AbstractforHuman induced pluripotent stem cell-derived hepatocytes for toxicology testing | Full Text | References | PDF (150.3 KB)
  • 2822 Views
  • 36 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers
Shuji Kinoshita & Kazuoki Kondo MD
Pages: 7-14
Published online: 26 Nov 2014
AbstractforEvaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers | Full Text | References | PDF (424.6 KB)
  • 897 Views
  • 19 CrossRef citations
  • 0Altmetric

Review

Review
Mitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders
Josef Finsterer MD PhD & Sinda Zarrouk-Mahjoub PhD
Pages: 15-24
Published online: 21 Oct 2014
AbstractforMitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders | Full Text | References | PDF (242.6 KB)
  • 695 Views
  • 19 CrossRef citations
  • 0Altmetric
Review
Safety issues and drug–drug interactions with commonly used quinolones
Antonios Douros MD, Katja Grabowski & Ralf Stahlmann
Pages: 25-39
Published online: 26 Nov 2014
AbstractforSafety issues and drug–drug interactions with commonly used quinolones | Full Text | References | PDF (528.6 KB)
  • 1236 Views
  • 31 CrossRef citations
  • 0Altmetric
Review
Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs’ antiplatelet effects
David Stepensky PhD & Gilad Rimon PhD
Pages: 41-52
Published online: 13 Oct 2014
AbstractforCompetition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs’ antiplatelet effects | Full Text | References | PDF (619 KB)
  • 562 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia
Imit Kaur PhD, Jonathan E Constance PhD, Ken M Kosak BS, Michael G Spigarelli MD PhD & Catherine MT Sherwin PhD
Pages: 53-65
Published online: 09 Dec 2014
AbstractforAn extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia | Full Text | References | PDF (301.9 KB)
  • 346 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Pharmacogenetics of coumarin anticoagulants in Brazilians
Guilherme Suarez-Kurtz MD PhD & Mariana R Botton PharmD PhD
Pages: 67-79
Published online: 25 Oct 2014
AbstractforPharmacogenetics of coumarin anticoagulants in Brazilians | Full Text | References | PDF (434.3 KB)
  • 152 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Effects of pesticide chemicals on the activity of metabolic enzymes: focus on thiocarbamates
Cécile Mathieu, Romain Duval (PhD Student) , Ximing Xu (PhD Student) , Fernando Rodrigues-Lima (Professor) & Jean-Marie Dupret (Professor)
Pages: 81-94
Published online: 13 Nov 2014
AbstractforEffects of pesticide chemicals on the activity of metabolic enzymes: focus on thiocarbamates | Full Text | References | PDF (510.4 KB)
  • 242 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems
Victor Voicu, Flavian Ştefan Rădulescu & Andrei Medvedovici
Pages: 95-109
Published online: 06 Nov 2014
AbstractforRelationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems | Full Text | References | PDF (666 KB)
  • 103 Views
  • 11 CrossRef citations
  • 0Altmetric

Drug Evaluation

Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder
Mariken Dinnissen MSc, Andrea Dietrich MSc PhD, Barbara J van den Hoofdakker MSc PhD & Pieter J Hoekstra MD PhD
Pages: 111-124
Published online: 11 Nov 2014
AbstractforClinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder | Full Text | References | PDF (332.1 KB)
  • 810 Views
  • 10 CrossRef citations
  • 0Altmetric
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes
Marianna Maranghi MD PhD, Anna Carnovale MD, Cosimo Durante MD PhD, Giovanna Tarquini MD, Giusy Tiseo MD & Sebastiano Filetti MD
Pages: 125-137
Published online: 24 Nov 2014
AbstractforPharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes | Full Text | References | PDF (391.2 KB)
  • 999 Views
  • 8 CrossRef citations
  • 0Altmetric
Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin
Frieder Keller, Ulla Ludwig & David Czock
Pages: 139-147
Published online: 03 Dec 2014
AbstractforPharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin | Full Text | References | PDF (499.7 KB)
  • 330 Views
  • 4 CrossRef citations
  • 0Altmetric
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
Roberto Mandrioli, Michele Protti & Laura Mercolini
Pages: 149-174
Published online: 06 Dec 2014
AbstractforEvaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder | Full Text | References | PDF (467.2 KB)
  • 496 Views
  • 11 CrossRef citations
  • 0Altmetric

Further Readings

Related articles
Page: 1
Published online: 12 Dec 2014
CitationforRelated articles | Full Text | PDF (88.2 KB)
  • 87 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications
Gianluca D’Onofrio et al.
Editorial | Published online: 31 May 2024
Free Access
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles